| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |